Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 920
of 46Next
1:

Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes.

Mbawuike IN, Zhang Y, Couch RB.

Respir Res. 2007 Jun 27;8:44.

PMID: 17597533 [PubMed - indexed for MEDLINE]

2:

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.

Epstein SL, Stack A, Misplon JA, Lo CY, Mostowski H, Bennink J, Subbarao K.

Int Immunol. 2000 Jan;12(1):91-101.

PMID: 10607754 [PubMed - indexed for MEDLINE]

3:

Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.

Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ.

J Immunol. 1999 Apr 1;162(7):4163-70.

PMID: 10201942 [PubMed - indexed for MEDLINE]

4:

Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit.

Mbawuike IN, Wyde PR.

Vaccine. 1993 Sep;11(12):1205-13.

PMID: 7903015 [PubMed - indexed for MEDLINE]

6:

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44.

PMID: 18355405 [PubMed - indexed for MEDLINE]

7:

Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.

Jenkins MR, Webby R, Doherty PC, Turner SJ.

J Immunol. 2006 Sep 1;177(5):2917-25.

PMID: 16920927 [PubMed - indexed for MEDLINE]

8:

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.

Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.

Arch Virol. 2006 May;151(5):921-31. Epub 2005 Nov 15.

PMID: 16292596 [PubMed - indexed for MEDLINE]

9:

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Vaccine. 2007 Jan 8;25(4):612-20. Epub 2006 Sep 7.

PMID: 17005299 [PubMed - indexed for MEDLINE]

10:

Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.

Anderson RW, Bennink JR, Yewdell JW, Maloy WL, Coligan JE.

Mol Immunol. 1992 Sep;29(9):1089-96.

PMID: 1495499 [PubMed - indexed for MEDLINE]

11:

Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein.

Etchart N, Desmoulins PO, Chemin K, Maliszewski C, Dubois B, Wild F, Kaiserlian D.

J Immunol. 2001 Jul 1;167(1):384-91.

PMID: 11418674 [PubMed - indexed for MEDLINE]

12:

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D.

Cell Immunol. 2001 Aug 1;211(2):143-53.

PMID: 11591118 [PubMed - indexed for MEDLINE]

13:

Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Nicholas JA, Rubino KL, Levely ME, Adams EG, Collins PL.

J Virol. 1990 Sep;64(9):4232-41.

PMID: 2117070 [PubMed - indexed for MEDLINE]

14:

Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.

Ohba K, Yoshida S, Zahidunnabi Dewan M, Shimura H, Sakamaki N, Takeshita F, Yamamoto N, Okuda K.

Vaccine. 2007 May 22;25(21):4291-300. Epub 2007 Mar 12.

PMID: 17403560 [PubMed - indexed for MEDLINE]

15:

Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection.

Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM.

Mech Ageing Dev. 2002 Apr 30;123(8):1167-81.

PMID: 12044966 [PubMed - indexed for MEDLINE]

16:

Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.

Kyburz D, Speiser DE, Battegay M, Hengartner H, Zinkernagel RM.

Eur J Immunol. 1993 Jul;23(7):1540-5.

PMID: 8325330 [PubMed - indexed for MEDLINE]

18:

The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells.

Townsend AR, Skehel JJ.

J Exp Med. 1984 Aug 1;160(2):552-63.

PMID: 6206181 [PubMed - indexed for MEDLINE]

19:

Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.

Stitz L, Schmitz C, Binder D, Zinkernagel R, Paoletti E, Becht H.

J Gen Virol. 1990 May;71 ( Pt 5):1169-79.

PMID: 1693165 [PubMed - indexed for MEDLINE]

20:

Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.

Wiley JA, Hogan RJ, Woodland DL, Harmsen AG.

J Immunol. 2001 Sep 15;167(6):3293-9.

PMID: 11544317 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 920
of 46Next